HAEMONETICS CORP
HAEMONETICS CORP
Share · US4050241003 · HAE · 881782 (XNYS)
Overview Financial Indicators
71,65 USD
1,69 % 1,19 USD
NYSE (XNYS) · Current prices and charts at MoneyPeak
09.06.2025 20:00

Current Prices from HAEMONETICS CORP

ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
HAE
USD
09.06.2025 20:00
71,65 USD
70,46 USD
+1,69 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 1,59 % 5,07 % 4,29 % -13,61 % -16,31 % -27,38 %

Company Profile for HAEMONETICS CORP Share

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Company Data

Name HAEMONETICS CORP
Company Haemonetics Corporation
Symbol HAE
Website https://www.haemonetics.com
Primary Exchange XNYS NYSE
WKN 881782
ISIN US4050241003
Asset Class Share
Sector Healthcare
Industry Medical - Instruments & Supplies
CEO Mr. Christopher A. Simon
Market Capitalization 3 Mrd.
Country United States of America
Currency USD
Employees 3,7 T
Address 125 Summer Street, 02110 Boston
IPO Date 1991-05-10

Stock Splits

Date Split
03.12.2012 2:1
11.01.1993 2:1

Ticker Symbols

Name Symbol
Frankfurt HAZ.F
NYSE HAE

More Shares

Investors who HAEMONETICS CORP hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BK MONTREAL 22/37 FLR
BK MONTREAL 22/37 FLR Bond
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
ELECTRONIC ARTS INC
ELECTRONIC ARTS INC Share
GLMR
GLMR Crypto
INTEL CORP
INTEL CORP Share
JPMORGAN CHASE & CO
JPMORGAN CHASE & CO Share
MICROSOFT CORP
MICROSOFT CORP Share
NXP SEMICONDUCTORS NV
NXP SEMICONDUCTORS NV Share
ODDO BHF AV.EURO CR-EUR
ODDO BHF AV.EURO CR-EUR Fund
USA 24/27
USA 24/27 Bond
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025